You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Harvard Business School
McKesson
Dow
Mallinckrodt

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

GRANISOL Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Granisol, and when can generic versions of Granisol launch?

Granisol is a drug marketed by Pediatrx and is included in one NDA.

The generic ingredient in GRANISOL is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.

Summary for GRANISOL
Drug patent expirations by year for GRANISOL
Recent Clinical Trials for GRANISOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tesaro, Inc.Phase 3
University of MiamiPhase 2

See all GRANISOL clinical trials

Synonyms for GRANISOL
007G998
007M998
1-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID (9-METHYL-9-AZA-BICYCLO[3.3.1]NON-3-YL)-AMIDE HYDROCHLORIDE
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide hydrochloride
1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide monohydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride
1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride
107007-99-8
109889-09-0 (Parent)
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, monohydrochloride, endo-
318F6L70J8
A801552
AB0105685
AC1OCEWF
AKOS025311206
ALM-101
API0002865
BCP9000731
BEMA-Granisetron
BRL 43694A
CAS-107007-99-8
CCG-101117
CHEBI:5538
CHEMBL1900758
CPD000469138
D00677
DSSTox_CID_28983
DSSTox_GSID_49057
DSSTox_RID_83248
DTXSID7049057
endo-1-Methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide hydrochloride
FT-0082684
FT-0626806
G0401
Granisetron hydrochloride
Granisetron hydrochloride (JAN/USAN)
Granisetron hydrochloride [USAN:USP]
Granisetron hydrochloride preservative free
Granisetron hydrochloride, >=98% (HPLC), solid
Granisetron hydrochloride, European Pharmacopoeia (EP) Reference Standard
Granisetron Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Granisetron hydrochloride, United States Pharmacopeia (USP) Reference Standard
Granisetron Hydrocholride
Granisetron-MDTS
Kytril
Kytril (TN)
Kytril Injection
MFCD01747034
MLS001401373
NC00367
NCGC00183873-01
SAM001246527
Sancuso
SCHEMBL34177
SCHEMBL34179
SMR000469138
SyB L-0701
TL8000249
Tox21_113607
UNII-318F6L70J8
W-5272

US Patents and Regulatory Information for GRANISOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pediatrx GRANISOL granisetron hydrochloride SOLUTION;ORAL 078334-001 Feb 28, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
AstraZeneca
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.